| Literature DB >> 26159425 |
Steffen Dreger1, Saskia Poettgen2, Florence Samkange-Zeeb3, Hiltrud Merzenich4, Anye Ningo5, Joachim Breckow6, Hajo Zeeb7,8.
Abstract
BACKGROUND: Exposure to medical ionizing radiation has been increasing over the past decades and constitutes the largest contributor to overall radiation exposure in the general population. While occupational exposures are generally monitored by national radiation protection agencies, individual data on medical radiation exposure for the general public are not regularly collected. The aim of this study was to determine the feasibility of assessing lifetime medical ionizing radiation exposure from diagnostic and therapeutic procedures retrospectively and prospectively within the framework of the German National Cohort study.Entities:
Mesh:
Year: 2015 PMID: 26159425 PMCID: PMC4702423 DOI: 10.1186/s13104-015-1268-8
Source DB: PubMed Journal: BMC Res Notes ISSN: 1756-0500
Study population characteristics
| Total study population (n = 199) | Highly exposed individuals (≥15 examinations) (n = 51) | |||
|---|---|---|---|---|
| n | % | n | % | |
| Sex | ||||
| Female | 112 | 56.3 | 33 | 64.7 |
| Male | 87 | 43.7 | 18 | 35.3 |
| Age (in years) | ||||
| <40 | 59 | 29.6 | 6 | 11.8 |
| 40–50 | 40 | 20.1 | 7 | 13.7 |
| >50 | 100 | 50.3 | 38 | 74.5 |
| Center | ||||
| Bremen | 99 | 49.7 | 27 | 52.9 |
| Hamburg | 100 | 50.3 | 24 | 47.1 |
Median number of self-reported examinations for X-ray and computed tomography examinations by total study population and highly exposed participants
| Total study population (n = 199) | Highly exposed individuals (>=15 examinations) (n = 51) | |||||||
|---|---|---|---|---|---|---|---|---|
| X-ray examinations (N = 199) | CT examinations (N = 83) | X-ray examinations (N = 51) | CT examinations (N = 51) | |||||
| n | Median (IQR) | n | Median (IQR) | n | Median (IQR) | n | Median (IQR) | |
| Body part | 7.0 (4.0–13.0) | 2.0 (1.0–3.0) | 17.0 (14.0–27.0) | 2.0 (2.0–5.5) | ||||
| Head | 81 | 2.0 (1.0–3.0) | 40 | 1.0 (1.0–1.0) | 28 | 2.0 (1.0–5.0) | 14 | 1.0 (1.0–2.0) |
| Thorax | 112 | 2.0 (1.0–4.5) | 15 | 1.0 (1.0–6.0) | 41 | 5.0 (2.0–8.0) | 10 | 4.5 (1.0–7.0) |
| Abdomen | 31 | 1.0 (1.0–1.0) | 15 | 1.0 (1.0–5.0) | 16 | 1.0 (1.0–2.5) | 11 | 1.0 (1.0–7.0) |
| Spine | 87 | 2.0 (1.0–3.0) | 27 | 1.0 (1.0–2.0) | 41 | 2.0 (1.0–4.0) | 14 | 1.5 (1.0–2.0) |
| Lower extremities | 118 | 2.0 (1.0–3.0) | 12 | 1.5 (1.0–2.0) | 41 | 3.0 (1.0–4.0) | 5 | 1.0 (1.0–2.0) |
| Upper extremities | 122 | 2.0 (1.0–3.0) | 2 | 1.5 (1.0–2.0) | 36 | 2.0 (2.0–4.0) | 2 | 1.5 (1.0–2.0) |
| Mammograms (females only) | 60 | 3.0 (2.0–6.0) | – | – | 28 | 5.5 (2.5–8.5) | – | – |
| Sex | ||||||||
| Female | 112 | 8.0 (4.0–14.0)* | 35 | 2.0 (1.0–4.0) | 33 | 17.0 (15.0–24.0) | 20 | 2.5 (2.0–5.5) |
| Male | 87 | 6.0 (3.0–11.0)* | 48 | 2.0 (1.0–3.0) | 18 | 16.5 (14.0–20.0) | 16 | 2.0 (2.0–7.0) |
| Age (in years) | ||||||||
| <40 | 59 | 4.0 (2.0–7.0)* | 14 | 1.0 (1.0–2.0) | 6 | 21.0 (18.0–26.0)* | 4 | 2.5 (1.5–5.0) |
| 40–50 | 40 | 7.0 (4.0–10.0)* | 17 | 2.0 (1.0–2.0) | 7 | 16.0 (14.0–30.0)* | 5 | 2.0 (2.0–4.0) |
| >50 | 100 | 10.0 (5.0–15.0)* | 52 | 2.0 (1.0–3.5) | 38 | 17.0 (14.0–24.0)* | 27 | 2.0 (2.0–6.0) |
| Center | ||||||||
| Bremen | 99 | 7.0 (4.0–13.0) | 39 | 1.0 (1.0–3.0) | 27 | 17.0 (14.0–23.0) | 18 | 2.0 (1.0–3.0)* |
| Hamburg | 100 | 7.0 (4.0–13.0) | 44 | 2.0 (1.0–2.0) | 24 | 17.0 (14.0–24.5) | 18 | 3.5 (2.0–6.0)* |
IQR interquartile range.
*Significant at p value <0.05.